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Abstract
Data on implementation of ‘Test and Treat’ among key populations in sub-Saharan Africa are still limited. We examined 
factors associated with prompt antiretroviral therapy/ART (within 1 month of HIV-positive diagnosis or 1 week if pregnant) 
among 343 women at high risk for HIV infection in Kampala-Uganda, of whom 28% initiated prompt ART. Most (95%) 
reported paid sex within 3 months prior to enrolment. Multivariable logistic regression was used to determine baseline char-
acteristics associated with prompt ART. Sex work as main job, younger age and being widowed/separated were associated 
with lower odds of prompt ART; being enrolled after 12 months of implementing the intervention was associated with higher 
odds of prompt ART. Younger women, widowed/separated and those reporting sex work as their main job need targeted 
interventions to start ART promptly after testing. Staff supervision and mentoring may need strengthening during the first 
year of implementing ‘test and treat’ interventions.
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Introduction
Throughout the world, key populations who include: sex 
workers, injecting drug users (IDU), men who have sex with 
men (MSM), transgender people and fisher-folk are dispro-
portionately burdened by the HIV epidemic [1–5]. These key 
populations and their sexual partners account for 10–51% of 
new infections in sub-Saharan Africa (SSA) [6–8]. System-
atic reviews show that in low and middle income countries 
(LMICs), female sex workers (FSWs) are 13.5 times more 
likely to have HIV compared to women in the general popu-
lation [1]. In Uganda, while the National HIV prevalence 
has stabilized at 7.3% [9], the prevalence is over 30% among 
FSWs [10].
The HPTN052 trial showed that immediate ART given 
to HIV-positive people dramatically reduced HIV-trans-
mission to their HIV-negative partners [11]. These results 
were received with considerable enthusiasm and the ‘end of 
AIDS’ heralded [12, 13]. In December 2013, the Ministry 
of Health (MoH), Government of the Republic of Uganda, 
issued an ‘Addendum to the National Antiretroviral Treat-
ment Guidelines’ which allowed provision of ART irre-
spective of CD4 T cell counts to the following HIV-posi-
tive groups: pregnant women and breast-feeding mothers, 
partners in sero-discordant couples, and people with active 
TB disease or Hepatitis B co-infection with severe chronic 
liver disease. In addition, it included the recommendation 
that key populations should initiate prompt ART [14] with 
the rationale that these groups were making a substantial 
contribution to new HIV infections. Following the START 
trial results [15], and the release of the WHO ‘Guidelines 
on when to start antiretroviral therapy and on pre-exposure 
prophylaxis for HIV’ [16], the global HIV response is now 
aimed at reducing HIV transmission by giving prompt ART 
to all HIV-positive people, a challenging and ambitious goal 
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Introduction section.
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[17]. This approach is called `Test and Treat’ or `Test and 
Start’ [18].
The studies that have assessed ‘test and treat’ in sub-Saha-
ran Africa (SSA) have shown that at least half of participants 
initiate prompt ART [19, 20]. In the PopART trial, the larg-
est so far to deliver ‘test and treat’ at population level, Hayes 
et al. report less than 45% ART uptake within 6 months with 
uptake being lower among the younger population [21]. 
Among MSM in Nigeria prompt ART was associated with 
disclosure of MSM status [20] while in a cluster randomised 
trial among the general population in South Africa, partici-
pants in the ‘test and treat’ arm were less likely to initiate 
ART if they had high CD4 T-cell counts, most likely because 
they were not sick [19]. Studies done among the general 
population elsewhere, and key populations such as MSM 
and FSWs also show that being in a healthy state [22–25] is 
associated with lower ART uptake. Fear of side effects [25, 
26] has been reported as another barrier to prompt ART.
The enthusiasm for `Test and Treat’ has been tempered 
by a growing recognition of the challenges that impede pro-
gress in providing treatment to everyone living with HIV 
[21, 27–31] and achieving the second ‘90’ of the UNAIDS 
90–90–90 targets. Despite these challenges, concerns over 
the spread of HIV [32] and the prospect of increased ART 
drug resistance in Africa [33] have increased efforts to 
facilitate the roll-out of treatment and identify barriers to 
initiating prompt ART. We build on work done in the gen-
eral population [19, 21] and MSM [20] to determine factors 
associated with prompt ART initiation among FSWs, who 
are criminalized in many parts of SSA and in whom the 
dynamics of treatment uptake may differ from the general 
population and settings that have decriminalized sex work. 
We hypothesize that treatment uptake will be different from 
that seen in the general population. We use data collected 
over 2 years and 8 months in a ‘Test and Treat’ intervention 
in Kampala, Uganda.
Methods
Study Design and Setting
We performed a retrospective cohort analysis of participant 
records within a research clinic implementing ‘Test and 
Treat’ among women at high risk for HIV infection, who 
attended the clinic between August 2014 and April 2017. 
The clinic (Good Health for Women Project Clinic-GHWP) 
was established in a peri-urban community in southern 
Kampala in 2008. Women attending the clinic engage in 
sex with men for money, goods or favors; the recruitment 
of women from commercial hotspots has been described 
elsewhere [10].
Women are enrolled into the GHWP clinic irrespective 
of HIV status, and invited for quarterly visits for HIV pre-
vention and care services. At enrolment, women are offered 
HIV counselling and testing (HCT) and receive same day 
results. HIV-positive participants received free HIV care 
including Tuberculosis screening and treatment, prophy-
laxis for opportunistic infections (OIs) and ART. ART was 
initiated using CD4 + T-cell counts (< 350 cells/µl) and 
WHO clinical stage criteria until August 2014 when the 
clinic implemented ‘Test and Treat’ in line with the new 
MoH guidelines.
Repeat HCT was done at quarterly follow up visits only 
for women who previously tested HIV-negative. The women 
received free services including treatment for common ill-
nesses, contraception, syndromic management of sexually 
transmitted infections (STIs), counselling for alcohol use 
disorders, male and female condoms and treatment for their 
children below 5 years. They were encouraged to refer their 
male regular partners to the clinic for HIV prevention, care 
and treatment interventions. Enrolment of women continued 
throughout the study period and field workers maintained 
contact details of enrolled participants.
Study Participants, Eligibility Criteria
We selected participants from all HIV-positive ART-naïve 
women who were newly enrolled in the clinic from August 
2014 to April 2017 and who were ≥ 18 years. In addition, 
all HIV-negative women who changed to HIV positive sta-
tus (HIV seroconversion) during the study period became 
eligible.
ART Preparation, Initiation and Follow up Process
Study counsellors gave group information sessions about 
the ‘Test and Treat’ guidelines to participants and the ben-
efits to their health and the wider community. Women were 
also counselled on disclosure, drug reactions and adher-
ence, and then individually assessed for readiness to start 
ART using the ART readiness checklist. Women who were 
ready, initiated ART on the same day. Those who opted 
out of same-day initiation continued to be counselled, 
and a plan made with the aim of initiating ART within 
7 days for pregnant women, and within 1 month for the 
others. Women were considered to have initiated prompt 
ART if they started treatment within 1 month or 1 week (if 
pregnant) of an HIV-positive diagnosis as per the “Con-
solidated guidelines for prevention and treatment of HIV 
in Uganda” [34]. Counselling sessions during clinic vis-
its continued for those who did not initiate prompt ART. 
They continued to be followed up at the clinic to receive 
free services and treatment of other illnesses, and could 
initiate ART when they were ready. The women initiated 
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first line treatment composed of two nucleoside reverse 
transcriptase inhibitors (NRTIs) and one non-nucleoside 
reverse transcriptase inhibitor (NNRTI); they were ini-
tially given 2 week’s treatment and scheduled for follow up 
2 weeks later but were free to return earlier if they experi-
enced side effects or other challenges. Women were then 
given treatment for 1 month, and the interval increased 
to 2 months’ treatment if they had no clinical events or 
adherence problems. Those who adhered and tolerated the 
drugs well were then given 3 months of treatment and 
scheduled for quarterly visits onwards. ART was provided 
free of charge throughout the study period. The women 
gave blood samples for laboratory monitoring according 
to the MoH guidelines. CD4 + T-cell counts were tested 
at baseline and every 6 months, and viral load monitoring 
after at least 6 months on ART.
Study Outcomes
Prompt ART initiation was defined as dispensing initial ART 
to an eligible participant within 1 month of an HIV-positive 
diagnosis or within 1 week if pregnant.
Independent variables were collected at the time of HIV 
diagnosis and included: socio-demographic variables (age, 
marital status, education level, religion, main job); behavio-
ral variables included: paid sex, substance use, contraceptive 
use and sexual partner violence in the 1 months prior to 
enrolment; condom use 1 month prior to enrolment and his-
tory of ever testing for HIV); one biological variable (CD4 
T-cell count). We also included a time variable that meas-
ured the duration between ‘test and treat implementation and 
becoming eligible.
Data Collection
Data on socio-demographics, sexual behavior, prior HIV 
testing, substance use, contraception and sexual partner 
violence were collected using electronic (MS Access) 
interviewer administered questionnaires during one on one 
private sessions held in clinic rooms with trained study 
counsellors. Alcohol use was assessed by using the Alcohol 
Use Disorders Identification Test (AUDIT) questionnaire 
which consists of 10 questions to assess alcohol use disor-
ders. Alcohol use was classified into two categories which 
included: low risk drinkers: score 0–7 and high risk drink-
ers: score 8 + . Data on ART start dates, duration on ART 
and prescriptions were recorded by clinicians. HIV results 
were recorded on laboratory source documents by laboratory 
staff while CD4 results were generated as print outs. Data on 
HIV results and ART were entered into OpenMRS by data 
management assistants.
Laboratory Methods
HIV testing was performed on serum using two or more 
rapid diagnostic tests for antibodies to HIV. Screening was 
performed using Determine. A non-reactive test result was 
given to the participant as HIV-negative while a reactive test 
was confirmed using Statpak. A reactive Statpak result was 
given to the participant as HIV-positive. Discordant deter-
mine and Statpak results, were subjected to a tie breaker 
test using Unigold. The result given by Unigold was taken 
as final for presence or absence of antibodies to HIV and 
results given to the participant.
CD4 testing was performed on plasma using Multi-test 
Trucount tube CD4/CD8/CD3-Lyse no wash (BD. USA).
Statistical Analysis
The MS Access and OpenMRS databases were merged into 
one database, cleaned, and exported to STATA 12.1 (Stata-
Corp, College Station, TX, USA) for analysis. Prompt ART 
initiation was a binary outcome (Yes initiated prompt ART; 
No did not initiate prompt ART). Participants’ categorical 
demographic and behavioral characteristics were summa-
rized by counts and percentages. Continuous characteristics 
were summarized by means and standard deviations (SD) 
or medians and inter quartile ranges. We determined the 
proportion who initiated prompt ART as the number that 
started ART within 1 month of eligibility (non-pregnant) 
or within 1 week (pregnant) divided by the total number 
eligible, and expressed as a percentage. The proportion who 
initiated prompt ART was further analyzed by the differ-
ent demographic and behavioral characteristics using Chi 
square tests. Logistic regression models were fitted to find 
factors associated with prompt ART initiation at unadjusted 
analysis; those for which the association attained statisti-
cal significance on log likelihood ratio test (LRT), p < 0.20 
were selected for the multivariable logistic regression model. 
We used complete case analysis to run our final model. 
Age was considered as a priori confounder. Factors were 
retained in the final multivariable logistic regression model 
if their inclusion did not make the model significantly worse 
at p < 0.05. Results are presented as adjusted odds ratios 
(AOR) with p values and 95% confidence intervals (CI).
Results
Recruitment Profile
The recruitment profile for participants is summarized in 
Fig. 1. From August 2014 to April 2017, we enrolled 2385 
women at high risk of HIV-infection at the GHWP clinic. 
Of these 847 were HIV-positive of whom 354 were not yet 
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on ART and were therefore eligible for ‘test and treat’. In 
addition, women joined the `test and treat cohort’ during the 
study period, because 44 participants who were HIV-neg-
ative became HIV-positive during the study period. There-
fore, a total of 398 (354 + 44) participants were eligible, 
of whom 343 had complete data for all variables and were 
included in our final analysis.
Characteristics of Study Participants
The mean (±  SD) age of study participants was 
28.9 ± 6.1 years. The majority (73.5%) were widowed or 
separated, 60.4% had primary level education and 65.6% 
were Christian. The median (IQR) CD4 + T-cell count at 
enrolment was 544 (327–775) cells/µl. Ninety-five percent 
of participants reported engaging in paid sex in the 3 months 
prior to enrollment. Overall, 65.3% of participants reported 
sex work as their main job, 20.1% mainly worked in enter-
tainment facilities (bars, night clubs and karaoke) and the 
rest reported having other main job(s) such as the hospi-
tality industry (restaurants, beauty and massage parlors, 
guest houses) or no job. High risk alcohol consumption was 
reported by 61.5% of all participants. Thirty-five percent 
consumed drugs, the most common being kuber/smoke-
less chewing tobacco and khat. Sexual partner violence was 
reported by 48.7% and was perpetrated by both casual part-
ners and marital partners. Details are shown in Table 1.
Factors Associated with Prompt ART Initiation
A total of 96 (28%) participants initiated prompt ART 
during the study period, the median time to ART initia-
tion being 6 days (IQR 0–14 days). At bivariate analysis, 
prompt ART initiation was less likely among women who 
reported sex work as their main job (OR sex work_vs_other 
job or no job: = 0.48, 95% CI 0.30–0.79), and young women 
(OR < 25_vs_ ≥ 35: = 0.39, 95% CI 0.20–0.77) and (OR 
25–29_vs_ ≥ 35: = 0.44, 95% CI 0.23–0.83). Prompt ART 
Fig. 1  Screening profile of study participants
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initiation was more likely among those who became eligible 
after 12 months of implementing the intervention (OR 1.79, 
95% CI 1.05–3.06) compared to those who became eligible 
during the first 12 months.
At adjusted analysis, when compared with women 
aged ≥ 35 years, prompt ART initiation was less likely 
among young women aged < 25 years; (AOR0.28, 95% CI 
0.13–0.61) and those aged 25–29 years (AOR 0.40, 95% CI 
0.20–0.79). Prompt ART was also less likely among women 
who reported sex work as their main job (AOR 0.44; 95% 
CI 0.25–0.78) compared to those reporting other job(s) or 
no job. Regarding marital status widowed/separated women 
were less likely to initiate prompt ART (AOR 0.45; 95% 
CI 0.23–0.86) compared to never married women. Those 
who became eligible for the ‘test and treat’ intervention after 
12 months of its implementation were more likely to initiate 
prompt ART (AOR 2.58; 95% CI 1.41–4.71) compared to 
those who became eligible during the first 12 months of the 
intervention as shown in Table 2.
Discussion
We found that a low proportion of women initiated prompt 
ART compared to other studies that have examined the 
delivery of the test and treat intervention [19–21]. Iwuji and 
colleagues, for example, report high ART uptake, however 
this was only observed in those who linked to care [35]; 
overall, ART uptake in that trial was still low considering 
that almost half of HIV-positive individuals did not link to 
care within 6 months. We report prompt ART as initiating 
within 1 month while others [20, 21, 35] have reported ini-
tiation between 3 and 6 months. The shorter duration may 
further explain lower uptake in our study.
Women who reported sex work as their main job were 
less likely to initiate prompt ART compared to those who 
reported other jobs or no job. Structural and social bar-
riers may hinder prompt ART initiation among FSWs in 
our setting where sex work is still criminalized. Com-
munities worldwide still exhibit varied levels of stigma 
Table 1  Sociodemographic and 
behavioural characteristics of 
study participants
Characteristic Categories Frequency 
(n = 343)
Percentage (%)
Age < 25 90 26.2
25–29 111 32.4
30–34 71 20.7
≥ 35 71 20.7
Education level No education 31 9.0
Attended primary 207 60.4
Attended Secondary or higher 105 30.6
Current marital status Never married 67 19.5
Married 24 7.0
Widowed/Separated 252 73.5
Religion Christian 225 65.6
Muslim and other 118 34.4
Main job Sex work 224 65.3
Entertainment 69 20.1
No job/other job 50 14.6
Paid sex in past 3 months Yes 324 94.5
No 19 5.5
Drinking pattern (AUDIT score) Low risk drinkers 132 38.5
High risk drinkers 211 61.5
Sexual partner violence in past 3 months Yes 167 48.7
No 176 51.3
HIV sero-conversion Yes 31 9.0
No 312 91.0
Ever tested for HIV  Yes 298 86.9
No 45 13.1
Drug use in past 3 months Yes 120 35.0
No 223 65.0
Time since T&T implementation 12 months 112 32.7
> 12 months 231 67.3
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and discrimination against FSWs [36, 37]. To avoid these 
negative consequences, many FSWs do not reveal their 
HIV-positive status to community members. Many do 
not want to be seen with pills because taking ART is 
one way of exposing their HIV-positive status making 
them lose clients and money [38]. The lifestyle of FSWs 
also poses barriers to prompt ART initiation because of 
working hours which do not allow time to make initial 
clinic visits to start and stabilize on treatment, and fear of 
being isolated from the FSW support structures if found 
Table 2  Multivariable model for factors associated with prompt ART initiation
Characteristic N (col %) Prompt 
ART N 
(row %)
Unadjusted OR (95% CI) LRT P value Adjusted OR (95% CI) P value
343 96(28)
Age 0.03
 ≥ 35 71(21.0) 30(42.3) 1 1
 < 25 90(26.0) 20(22.2) 0.39(0.20–0.77) 0.28(0.13–0.61) 0.001
 25–29 111(32.0) 27(24.3) 0.44(0.23–0.83) 0.40(0.20–0.79) 0.009
 30–34 71(21.0) 19(26.8) 0.50(0.25–1.01) 0.54(0.26–1.16) 0.116
Current marital status 0.106
 Never married 67(19.5) 23(34.3) 1 1
 Married 24(7.0) 10(41.7) 1.37(0.53–3.55) 0.80(0.28–2.34) 0.69
 Widowed/separated 252(73.5) 63(25.0) 0.64(0.36–1.14) 0.45(0.23–0.86) 0.016
Religion 0.441
 Muslim and other 118(34.4) 30(25.4) 1
 Christian 225(65.6) 66(29.3) 1.22(0.74–2.02)
Education level 0.935
 No education 31(9.0) 9(29) 1
 Primary 207(60.4) 59(28.5) 0.97(0.42–2.24)
 Secondary or higher 105(30.6) 28(26.7) 0.89(0.37–2.16)
Main job 0.004
 No job/other jobs 119(34.7) 45(37.8) 1 1
 Sex work 224(65.3) 51(22.8) 0.48(0.30–0.79) 0.44(0.25–0.78) 0.005
Paid sex in past 3 months 0.174
 No 19(5.5) 8(42.1) 1 1
 Yes 324(94.5) 88(27.2) 0.51(0.20–1.32) 0.89(0.30–2.69) 0.838
Drinking pattern (AUDIT score) 0.083
 Low risk drinkers 132(38.5) 44(33.3) 1 1
 High risk drinkers 211(61.5) 52(24.6) 0.65(0.41–1.06) 0.61(0.35–1.04) 0.072
Drug use in past 3 months 0.722
 Yes 120(35.0) 61(27.3) 1 1
 No 223(65.0) 35(29.2) 1.09(0.67–1.79) 1.50(0.85–2.66) 0.161
Sexual partner violence in past 3 months 0.167
 No 176(51.3) 55(31.2) 1 1
 Yes 167(48.7) 41(24.6) 0.72(0.45–1.15) 0.67(0.39–1.14) 0.137
HIV sero-conversion 0.775
 No 312(91.0) 88(28.2) 1
 Yes 31(9.0) 8(25.8) 0.89(0.38–2.05)
Ever tested for HIV 0.235
 No 45(13.1) 16(35.6) 1
 Yes 298(86.9) 80(26.9) 0.67(0.34–1.29)
Time since T&T implementation 0.029
 ≤ 12 months 112(32.7) 23(20.5) 1 1
 > 12 months 231(67.3) 73(31.6) 1.79(1.05–3.06) 2.58(1.41–4.71) 0.002
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taking ART [38, 39]. Increased efforts are needed to cre-
ate a sex worker-supportive environment and partnerships 
using community mobilization among FSWs in order to 
facilitate universal access to HIV prevention services and 
identify acceptable ART delivery strategies [40].
In our study women aged less than 30 years had a lower 
likelihood of prompt ART initiation; the odds were how-
ever lower among young women (< 25 years) compared to 
those aged 25–29 years. Studies done among key popula-
tions elsewhere [24, 41–43], and the general population 
have also found prompt ART initiation less likely among 
young people. Initiation of prompt ART at a young age 
means, potentially, many years on ART; this requires 
a lifelong commitment which may not be a priority for 
young HIV-positive people who are not sick. In addition, 
young people are not fully economically independent and 
may not have resources to support clinic visits for ART 
initiation and early follow required before they are stable 
on treatment. In sex work settings, younger HIV-positive 
women experience more unequal power relations, gender 
inequities, limited social support and intimate partner 
violence when compared to older women [44], which 
affects their ability to engage with community social ser-
vices including initiating prompt ART [45].
We observed that ART initiation was less likely among 
widowed and separated women compared to those who 
were never married. Similar findings have been reported 
from the general population in sub-Saharan Africa [46, 
47] and elsewhere [48]. Widowhood and divorce/separa-
tion are still associated with stigma and shame in many 
developing communities [49, 50]. Widows and separated/
divorced women may experience rejection and violence 
from in-laws and former spouses [49–52]. This social 
marginalization coupled with engagement in sex work 
may further reduce their opportunities for a social sup-
port system that facilitates disclosure of HIV status and 
the subsequent decision to initiate ART.
We found that women who were more recently enrolled 
in the cohort (after 12 months of implementing ‘test and 
treat’), were more likely to initiate prompt ART. This 
finding is consistent with other studies [22, 53, 54]. We 
attribute the higher likelihood of prompt ART initiation in 
later months to increased staff confidence and experience 
with the new ART initiation guidelines. It is also likely 
that the intervention was more popular among the women 
after 1 year of implementation increasing the likelihood 
of prompt ART initiation. We however note, that even 
though prompt ART initiation was more likely among 
the recently enrolled women, the proportion who initiated 
was still very low suggesting that staff experience alone 
does not lead to improved ART uptake.
Study Limitations
One of our main limitations was missing data on one or more 
variables for 55 women that were excluded from the final 
analysis. This could have reduced our power of predicting 
prompt ART initiation. We did not assess for health facility 
factors, the study staff received training before and during 
implementation of test and treat, drugs, clinic and laboratory 
supplies and registers for documentation were always avail-
able. Women received comprehensive health care in addition 
to HIV care and treatment; the role of the health facility 
could have been limited. Furthermore, we did not collect 
data on the reasons for non-uptake of prompt ART for those 
that did not initiate. Such data could inform future strategies 
aimed at improving prompt ART among key populations.
Conclusion
We found a low uptake of prompt ART among FSWs. Our 
findings provide information that highlights the need to tar-
get young women, those whose main job is sex work, and 
the widowed/separated for prompt ART initiation. FSWs 
should be involved in the design and implementation of tai-
lored interventions that provide an enabling environment 
to support them. This approach together with community 
engagement activities through peer educators and health 
workers enables close follow up of all HIV positive FSWs 
for purposes of continued education about prompt ART and 
could play an important role in prompt ART initiation and 
increased ART coverage in this population. In addition, reg-
ular supervision and mentoring activities for clinical care 
need more support during the first year; they include but 
are not limited to: staff training, ART knowledge and skills 
assessment, document review to ensure accurate and consist-
ent data capture and participant satisfaction surveys.
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